Proteomics is the comprehensive study of proteins produced by a biological system, including their identities, quantities, structures, modifications, interactions, locations and changes under different physiological or environmental conditions. The term refers to the protein complement, or proteome, associated with a cell, tissue, organism or biological state. Proteomics complements genomics because genes encode potential protein products, whereas proteins are major molecular agents that perform cellular functions such as catalysis, transport, signalling, structural support, molecular recognition and regulation.
A genome can remain relatively stable across many cells, while the proteome can change rapidly according to cell type, developmental stage, disease state, nutrient availability, stress, signalling and environmental conditions. Proteomics therefore provides a functional layer between genetic information and observable cellular behaviour. It combines biochemistry, analytical chemistry, molecular biology, mass spectrometry, computational analysis and statistics, and its scope ranges from identifying a single protein to characterising thousands of proteins and their modifications in complex biological samples.
The proteome is dynamic and context dependent. A cell does not express every gene simultaneously, and even when a gene is transcribed, the resulting RNA may be translated at different rates or degraded before producing substantial protein. Proteins can also undergo alternative splicing, proteolytic processing and post translational modification, producing multiple molecular forms from related genetic information. Common post translational modifications include phosphorylation, acetylation, methylation, glycosylation, ubiquitination and oxidation, each of which can alter protein activity, stability, localisation or interactions.
Proteomics can therefore distinguish between protein abundance and protein functional state. The term protein isoform is used for distinct molecular forms that arise through mechanisms such as alternative splicing or alternative processing. Protein complexes add another level of organisation because many cellular functions depend on assemblies of multiple proteins rather than isolated molecules.
Mass spectrometry is one of the principal technologies used in modern proteomics. In a typical workflow, proteins are extracted from a biological sample, digested into peptides, separated chromatographically and introduced into a mass spectrometer. The instrument measures mass to charge ratios and fragmentation patterns, which can be compared with sequence databases to identify peptides and infer the proteins from which they originated.
Bottom up proteomics analyses peptides generated by digestion, whereas top down proteomics attempts to analyse intact proteins and can provide more direct information about proteoforms. Data dependent acquisition traditionally selects particular precursor ions for fragmentation, while data independent acquisition systematically fragments broader sets of ions and can provide more reproducible quantitative information. Label free quantification compares signal intensities across samples, while stable isotope labelling and related methods introduce controlled mass differences that can facilitate quantitative comparisons.
Protein identification alone is only one component of proteomics. Quantitative proteomics attempts to determine how protein abundance differs between samples, while phosphoproteomics, glycoproteomics, ubiquitinomics and other specialised approaches focus on particular classes of modifications. Structural proteomics investigates protein conformations and complexes, and interactomics examines physical or functional relationships between proteins. Protein localisation can be investigated using imaging, biochemical fractionation or spatial proteomic approaches.
Single cell proteomics seeks to characterise protein variation between individual cells, addressing heterogeneity that can disappear when thousands or millions of cells are averaged together. Spatial proteomics combines molecular measurements with information about where proteins occur within cells or tissues. These approaches demonstrate why the proteome cannot be represented adequately by a simple list of protein names; biological meaning depends on quantity, molecular state, localisation, interaction and temporal context.
Proteomics is widely used in biomedical research because altered protein abundance or modification can accompany disease. Cancer proteomics can reveal changes in signalling pathways, metabolism, structural proteins and drug response. In infectious disease research, proteomics can identify pathogen proteins, host responses and potential diagnostic markers. Clinical proteomics investigates proteins in blood, urine, cerebrospinal fluid and other samples, although translating candidate biomarkers into reliable clinical tests requires extensive validation.
Proteomics is also important in pharmaceutical development because drug targets are proteins in many cases, and changes in protein pathways can help determine pharmacodynamic effects. In agriculture, proteomic studies examine plant responses to drought, pathogens, temperature, nutrients and other conditions, while industrial biotechnology uses proteomics to understand microbial production systems and optimise biological processes.
Protein structure is closely connected to function, and proteomics increasingly intersects with structural biology. A protein's amino acid sequence constrains its folding, but cellular conditions, molecular partners and post translational modifications influence the final functional state. Techniques such as nuclear magnetic resonance spectroscopy, X ray crystallography and cryo electron microscopy can provide structural information, although these methods have different requirements and limitations.
Computational prediction has become increasingly important because modern algorithms can estimate structures for many proteins from sequence information, but predicted structure should not automatically be treated as proof of physiological conformation or function. Proteomic measurements can help connect sequence, structure and abundance by determining which proteins are present and in what molecular forms. Integration with structural data can therefore reveal how genetic variation or chemical modification changes molecular behaviour.
Proteomics faces significant technical challenges because biological samples contain proteins with enormous differences in abundance, dynamic range and chemical properties. Highly abundant proteins can obscure low abundance molecules, incomplete digestion can affect peptide representation, and certain modifications may be difficult to detect reliably. Protein inference can also be complicated when multiple proteins share peptide sequences. Sample preparation, instrument settings, database quality and statistical thresholds influence results.
False discovery rate control is essential because thousands or millions of peptide spectrum matches may be evaluated simultaneously. Quantitative measurements also require careful experimental design, appropriate biological replication and control of technical variation. A detected protein should not automatically be interpreted as active, causative or functionally important. Proteomics therefore requires integration with biochemical validation, genetic evidence, cellular experiments and other molecular measurements when conclusions concern mechanism rather than simple molecular presence.
Proteomics has evolved from two dimensional gel electrophoresis and relatively small scale protein identification into highly multiplexed mass spectrometry based analysis capable of surveying extensive portions of complex proteomes. The field increasingly participates in multiomics research, where genomic variants are connected to RNA expression, protein abundance, protein modification and metabolic changes. This integration is important because biological regulation occurs across multiple molecular layers and changes at one level do not necessarily propagate linearly to another.
Quantitative and single cell technologies are expanding the resolution of proteomics, while improved instrumentation and computational methods continue to increase sensitivity and throughput. Proteomics consequently occupies a central position in modern molecular biology by providing information about the molecular machinery that actually carries out many cellular processes, while also revealing the substantial difference between genetic potential and realised cellular function.
